By using our site you consent to the CTFN Privacy Policy, Cookies Policy, and Terms of Service.

OK

EQT’s Raised Offer for Karo Still Facing Some Resistance

On January 2, EQT increased its offer for Karo Pharma from SEK 36.90 per share to SEK 38.00. EQT succeeded in garnering 29.1% of the shares via acceptances of the original offer, and had purchased 19.3% outside of the offer, taking its potentialfeatured

EQT Likely Will Need to Sweeten Bid for Karo Pharma

Private equity firm EQT likely will need to raise its offer to get individual dissenting shareholders of Karo Pharma onboard, a source close to the shareholder group told CTFN.featured

X

Interested in a trial?

Simply fill out the form below and one of our representatives will be in touch.